Versigent earnings loom as investors eye post-spinoff momentum

Versigent Ltd, spun off from Aptiv PLC in 2026, is set to report Q3 earnings. Analysts expect EPS of $1.78 on revenue of $2.41B, down from Q2. The stock trades at $40.98 with a consensus price target of $56.78. Investors will watch demand trends, capital allocation, and margins.

Original reporting
Published Nov 3, 2026, 3:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 3:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$VGNT
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

Low
01

Why it matters

The earnings preview sets expectations; investors will watch EPS, revenue, and margin guidance closely.

02

Market read

First earnings report for the newly independent company; could validate or challenge the spinoff thesis.

03

What to watch

Potential supply‑chain constraints or macro‑economic headwinds could weigh on margins despite a strong prior quarter.

Relevance 4/10Novelty 2/10Timing: pre‑market Wednesday

Background

Versigent spun off from Aptiv in March 2026 and has been trading independently for seven months.

Market effects

Results will inform views on the automotive electrical‑architecture sector and spinoff valuations.

Limited to U.S. investors focused on automotive suppliers.

Modest; primarily affects niche automotive component investors.

Counterpoint

If the market overestimates growth, a miss could trigger a sharper sell‑off than implied.

Key entities

  • Versigent Ltd

    Automotive electrical‑architecture supplier, recently spun off from Aptiv.

Related articles

$VGNTHigh

Versigent: Q3 Earnings Snapshot

Versigent PLC reported Q3 earnings of $102 million, or $1.41 per share, exceeding expectations. Adjusted EPS was $1.91. Revenue was $2.45 billion, also surpassing forecasts. The company expects full-year revenue of $9.5B to $9.6B.

$VGNTHigh

Versigent Reports Third Quarter 2026 Results

Versigent PLC (VGNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. PRESS RELEASE Versigent Reports Third Quarter 2026 Results Raises Full-Year 2026 Guidance Midpoints for Net Sales and Free Cash Flow 1 , Tightens All Guidance Ranges, Raises Upper End of Free Cash Flow 1 Guidance; Declares Quarterly Dividend SCHAFFHAUSEN, Switzerland, November 4,

$VGNTHighAI 8/10

Versigent beats Q3 estimates but shares dip on guidance

Versigent PLC (NYSE:VGNT) reported Q3 adjusted EPS of $1.91, beating estimates by $0.13, with revenue of $2.45B, up 7.2% YoY. Despite this, shares fell 1.35% after-hours due to guidance. The company raised full-year revenue guidance to $9.5B-$9.6B and increased free cash flow guidance to $275M-$325M. Adjusted EBITDA grew 10.9% YoY to $275M, with margins expanding 40 basis points.

High

Why Versigent Is Dropping 6.1%: Goldman Sachs Maintains Buy

Versigent PLC shares fell 6.1% to $44.50 after Goldman Sachs reduced its price target from $59 to $58, citing a cautious near-term outlook. The firm maintained a Buy rating, suggesting long-term confidence. Trading volume surged to 295,421 shares, reflecting heightened selling pressure. Investors reacted strongly to the modest target cut, potentially indicating broader sector concerns.

$VGNTMedAI 8/10

Versigent Q2 Earnings Call Highlights

Versigent (NYSE:VGNT) reported Q2 net income growth despite $35M incremental interest expense from 1Q 2026 debt financing. Adjusted tax rate rose to 27% from 16% year ago. Sales grew in Asia-Pacific and Americas, fell in EMEA. Copper costs pressured margins, but pass-through recoveries eased. 2026 net sales guidance raised to $9.4B-$9.6B; dividend $0.13 declared.